Journal Articles
2020

COVID-19 Induced Myocarditis: A Rare Cause of Heart Failure.
Q. Z. Iqbal
Northwell Health

M. A. Haider
S. B. A. Sattar
Northwell Health

M. Hanif
I. Javid

Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Internal Medicine Commons

Recommended Citation
Iqbal QZ, Haider MA, Sattar SB, Hanif M, Javid I. COVID-19 Induced Myocarditis: A Rare Cause of Heart
Failure.. . 2020 Jan 01; 12(11):Article 7398 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/7398. Free full text article.

This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic
Works. It has been accepted for inclusion in Journal Articles by an authorized administrator of Donald and Barbara
Zucker School of Medicine Academic Works. For more information, please contact academicworks@hofstra.edu.

Open Access Case
Report

DOI: 10.7759/cureus.11690

COVID-19 Induced Myocarditis: A Rare Cause of
Heart Failure
Qasim Z. Iqbal 1 , Muhammad Adnan Haider 2 , Saud Bin Abdul Sattar 1 , Muhammad Hanif 3 , Ishaq Javid 4
1. Internal Medicine, Northwell Health, New York City, USA 2. Internal Medicine, Allama Iqbal Medical College/Jinnah
Hospital, Lahore, PAK 3. Internal Medicine, Khyber Medical College Peshawar, Peshawar, PAK 4. Internal Medicine,
Marshfield Clinic, Marshfield, USA
Corresponding author: Qasim Z. Iqbal, q.z.iqbal@gmail.com

Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing lung injury has been well
documented in the literature recently. They do so primarily by binding to the membrane-bound form
of angiotensin-converting enzyme 2 (ACE-2) receptors. However, since these receptors are also expressed in
the heart and blood vessels, coronavirus can also cause damage to these organs by binding to the ACE-2
receptors. A typical case of coronavirus disease 2019 (COVID-19) usually presents with respiratory
symptoms like cough and shortness of breath accompanied by fever. The literature regarding this pandemic
has been growing and now we know very well that the effect of this deadly virus is not restricted to the lungs
alone. It can, unfortunately, cause various other complications ranging from neurological damage to even
myocardial injury in rare cases. We present an interesting case of a 40-year-old male patient who presented
to us with shortness of breath. When further investigated, the patient was found to have a new onset of
heart failure secondary to COVID-19 induced myocarditis.
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Introduction
Coronavirus disease 2019 (COVID-19) has been found responsible for thousands of deaths all over the world.
COVID-19 typically presents as fever, cough, fatigue, and headache. However, it has also been found to
inflict neurological and myocardial damage on the patients [1]. Myocardial damage associated with COVID19 has been found and recognized in recent literature [2]. These cardiovascular complications may include
but are not restricted to myocarditis, myocardial infarction, dysrhythmias, and thromboembolic events. The
first case of fulminant myocarditis secondary to COVID-19 was reported by Zeng et al. [3]. However, since
this relatively rare complication can be easily missed by physicians, we emphasize with our case report the
importance to keep a lookout for COVID-19 induced severe myocarditis in patients presenting with COVID19 symptoms.

Case Presentation
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A 40-year-old male with a past medical history of Type 2 diabetes mellitus presented to the ED with three
days history of orthopnea, dyspnea, and productive cough. He presented to us during the peak of the
COVID-19 pandemic and due to his characteristic symptoms, he was swabbed for the virus. The test came
out positive. On his initial assessment, he had a rectal body temperature of 98°F, a systolic blood pressure of
90/50 mmHg, a heart rate of 114 beats per minute, a respiratory rate of 32 breaths per minute, and upon
checking his pulse oximetry his oxygen saturation was found to be 82%. His physical examination was
prominent for jugular vein distention, bilateral pedal edema, bi-basilar crepitations, and an S3 gallop. An
initial diagnosis of acute heart failure was made and the patient was started on inotropic support and put on
oxygen via nasal cannula.
His blood work was done (Table 1) and the investigations showed an elevation in his white blood cell (WBC)
count, lactate dehydrogenase (LDH), C-reactive protein (CRP), blood urea nitrogen (BUN), creatine kinase,
and troponin levels. The initial electrocardiogram (ECG) done showed sinus tachycardia. An echocardiogram
(Table 2) was also done which revealed an ejection fraction of 21%-25% with moderate pulmonary
hypertension with moderate mitral and tricuspid regurgitation. The patient was stabilized and taken for
cardiac catheterization which showed no evidence of coronary artery occlusion. The patient was then taken
for a cardiac MRI which revealed features of myocarditis (inflammatory hyperemia, edema, necrosis,
contractile dysfunction, and accompanying pericardial effusion).
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Test

Result

Hemoglobin

10.9 g/dL

WBC count

16.9 (x109/L)

Red blood cell count

3.8 (x1012/L)

Platelets

370 (x109/L)

Cardiac troponin I

7.3 ng/mL

Prothrombin time

15 s (12 s control)

Activated partial thromboplastin time

30 s (28 s control)

CRP

42 mg/Dl

LDH

701 U/L

Serum ferritin level

954.3 µg/L

BUN

52 mg/dL

Creatinine

1.1

BNP

1710 pg/mL

Creatine kinase

322 U/L

TABLE 1: Initial laboratory investigations.
WBC, white blood cell; CRP, C-reactive protein; LDH, lactate dehydrogenase; BNP, brain natriuretic peptide; BUN, blood urea nitrogen

Left atrial dimension

42 mm (normal range 19-40 mm)

Left ventricle end diastolic dimension

57 mm (normal range 36-56 mm)

Right ventricular dimension

30 mm (normal range 08-26 mm)

Fractional shortening

12%

Ejection fraction

21%-25% (normal range 55%-65%)

RVSP

58 mmHg

TABLE 2: Echocardiography findings.
RVSP, right ventricular systolic pressure

He was treated with dexamethasone, remdesevir, lasix, low doses of lisinopril, and metoprolol. His condition
improved with the resolution of underlying viremia and he was discharged after 16 days of inpatient stay.
He was advised to follow up with the cardiologist and primary medical doctor after two weeks.

Discussion
The SARS-CoV-2 infection has been linked to a number of cardiovascular complications such as myocardial
infarction, thromboembolic events, and myocarditis [1]. The first endomyocardial biopsy (EMB) proven case
of myocardial inflammation in a COVID-19 patient was reported by Sala et al. [4].
The myocardial damage associated with SARS-CoV-2 infection has been proposed to be caused by:
1) Direct inoculation of the virus into the myocardium. SARS-CoV-2 uses its spike protein which is primed
by transmembrane serine protease 2 (TMPRSS2) to bind to angiotensin-converting enzyme 2 (ACE-2) which
facilitates cell entry. Thereafter, intracellularly, SARS-CoV-2 impairs the stress granule formation and
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without the stress granules, the virus replicates and damages the cell.
2) Immune response triggered by viral infection [5]. T lymphocytes are primed for viral antigens via antigenpresenting cells. The primed T lymphocytes migrate to the cardiomyocytes and trigger inflammation
through cell-mediated cytotoxicity. The T lymphocyte activation is augmented in the cytokine storm
syndrome, which results in a vicious positive feedback loop of immune activation and myocardial damage.
It is still not clear whether the pathogenesis of myocarditis is due to one of these mechanisms or both.
Further studies are needed to provide clear information regarding it.
The clinical presentation varies; patients might present with mild symptoms such as excessive tiredness to
in other cases presenting with acute heart failure. The diagnosis would require finding the presence of viral
particles in the myocardium. The American Heart Association and European Society of Cardiology both
currently recommend an EMB as the definitive diagnostic tool for myocarditis [6-7]. Furthermore, we have to
rule out other similar clinical conditions based on a thorough history and clinical evidence. Investigations
would include laboratory workup [inflammatory markers, cardiac enzymes, brain natriuretic peptide (BNP),
and WBC], ECG, echocardiogram, cardiovascular MRI, and in some cases cardiac catheterization.
Our case shows a young patient without any comorbidities or previous heart disease who got a viral
infection and developed myocardial inflammation within days [8]. Viral myocarditis in young adults is
usually fulminant and hence unfortunately fatal in most cases [9]. Therefore, it is of utmost importance to
distinguish fulminant myocarditis from a case of sepsis in the ER because fluid resuscitation would likely
worsen the underlying fulminant myocarditis. Recent studies have further pointed out that myocarditis
caused by coronavirus can present without the typical respiratory symptoms [10-11]. This only reinforces the
importance of a detailed and in-depth history during the initial encounter with the patient in the ER.

Conclusions
Myocardial damage due to COVID-19 has proven to be directly related to higher mortality in these patients.
This is particularly true for myocarditis which can very easily cause a rapid deterioration in COVID-19
patients. SARS-CoV-2 damages the heart, by causing both structural and functional changes in the
myocardium. Therefore, physicians should be extremely vigilant during this pandemic about the possibility
of myocardial complications in COVID-19 patients as early diagnosis followed by accurate and precise
management can potentially save the patient's life.
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